Literature DB >> 3582431

[Psychological and social anhedonia. Evaluation of a research instrument for measuring a basic psychopathologic disorder].

G Burgdörfer, M Hautzinger.   

Abstract

Scales for the measurement of social and physical anhedonia, the lowered ability to experience pleasure, were investigated. Both scales were devised by Chapman et al. German versions of these two patient populations and two groups of normal subjects. The reliability and scale intercorrelation coefficients were acceptable for the scales overall, but not for the separate subscales. Patients scored higher on both scales than normal subjects, and patients with neurotic depression had higher scores than those with a diagnosis of schizophrenia. A significant correlation with a chronic course was identified in the schizophrenic patients. Item analysis and factor analysis did not reveal any significant common dimensions in the 87 items in the original scales. Only 17 items in the physical anhedonia scale and 26 items in the social anhedonia scale met test-theoretical criteria of acceptability for inclusion in a German version of these scales. Discrepancies and congruencies between American and German studies were discussed, as were further criteria that might make it possible to improve research instruments of this kind.

Entities:  

Mesh:

Year:  1987        PMID: 3582431     DOI: 10.1007/bf00383852

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Neurol Sci        ISSN: 0175-758X


  12 in total

1.  Endogenomorphic depression. A conceptual and terminological revision.

Authors:  D F Klein
Journal:  Arch Gen Psychiatry       Date:  1974-10

2.  Possible etiology of schizophrenia: progressive damage to the noradrenergic reward system by 6-hydroxydopamine.

Authors:  L Stein; C D Wise
Journal:  Science       Date:  1971-03-12       Impact factor: 47.728

Review 3.  Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame.

Authors:  H S Akiskal; W T McKinney
Journal:  Arch Gen Psychiatry       Date:  1975-03

4.  Evaluation of contingencies and conditional probabilities. A psychophysiological approach to anhedonia.

Authors:  W Lutzenberger; N Birbaumer; B Rockstroh; T Elbert
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1983

5.  Body-image aberration in Schizophrenia.

Authors:  L J Chapman; J P Chapman; M L Raulin
Journal:  J Abnorm Psychol       Date:  1978-08

6.  Reliabilities and intercorrelations of eight measures of proneness to psychosis.

Authors:  L J Chapman; J P Chapman; E N Miller
Journal:  J Consult Clin Psychol       Date:  1982-04

7.  Physical anhedonia and schizophrenia.

Authors:  J Schuck; D Leventhal; H Rothstein; V Irizarry
Journal:  J Abnorm Psychol       Date:  1984-08

8.  Anhedonia and schizophrenia.

Authors:  M Cook; F Simukonda
Journal:  Br J Psychiatry       Date:  1981-12       Impact factor: 9.319

9.  [Schizophrenia--a provisional convention. On the problem of a nosography of schizophrenias (author's transl)].

Authors:  G Gross; G Huber
Journal:  Psychiatr Prax       Date:  1978-05

10.  Assessing anhedonia in psychiatric patients.

Authors:  J Fawcett; D C Clark; W A Scheftner; R D Gibbons
Journal:  Arch Gen Psychiatry       Date:  1983-01
View more
  8 in total

1.  Reward System Dysfunction as a Neural Substrate of Symptom Expression Across the General Population and Patients With Schizophrenia.

Authors:  Joe J Simon; Sheila A Cordeiro; Marc-André Weber; Hans-Christoph Friederich; Robert C Wolf; Matthias Weisbrod; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2015-05-25       Impact factor: 9.306

2.  Expanding the positivity offset theory of anhedonia to the psychosis continuum.

Authors:  Marcel Riehle; Matthias Pillny; Tania M Lincoln
Journal:  Schizophrenia (Heidelb)       Date:  2022-05-03

3.  Social anhedonia in major depressive disorder: a symptom-specific neuroimaging approach.

Authors:  Verena Enneking; Pia Krüssel; Dario Zaremba; Katharina Dohm; Dominik Grotegerd; Katharina Förster; Susanne Meinert; Christian Bürger; Fanni Dzvonyar; Elisabeth J Leehr; Joscha Böhnlein; Jonathan Repple; Nils Opel; Nils R Winter; Tim Hahn; Ronny Redlich; Udo Dannlowski
Journal:  Neuropsychopharmacology       Date:  2018-11-27       Impact factor: 7.853

4.  Mood-congruent amygdala responses to subliminally presented facial expressions in major depression: associations with anhedonia.

Authors:  Anja Stuhrmann; Katharina Dohm; Harald Kugel; Peter Zwanzger; Ronny Redlich; Dominik Grotegerd; Astrid Veronika Rauch; Volker Arolt; Walter Heindel; Thomas Suslow; Pienie Zwitserlood; Udo Dannlowski
Journal:  J Psychiatry Neurosci       Date:  2013-07       Impact factor: 6.186

5.  Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia.

Authors:  Henrik Walter; Hannes Kammerer; Karel Frasch; Manfred Spitzer; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2009-06-12       Impact factor: 4.530

6.  Does childhood trauma predict schizotypal traits? A path modelling approach in a cohort of help-seeking subjects.

Authors:  Julian Max Bernhard Dizinger; Carolin Martha Doll; Marlene Rosen; Michael Gruen; Lukas Daum; Frauke Schultze-Lutter; Linda Betz; Joseph Kambeitz; Kai Vogeley; Theresa Katharina Haidl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-04       Impact factor: 5.760

7.  A novel construct of anhedonia revealed in a Chinese sample via the Revised Physical and Social Anhedonia Scales.

Authors:  Qiongqiong Wu; Jiayue He; Shulin Fang; Panwen Zhang; Xingwei Luo; Jianghua Zhang; Yan Xiong; Fusheng Luo; Xiaosheng Wang; Shuqiao Yao; Xiang Wang
Journal:  BMC Psychiatry       Date:  2020-11-09       Impact factor: 3.630

8.  Understanding the neurobiological basis of anhedonia in major depressive disorder - evidence for reduced neural activation during reward and loss processing.

Authors:  Udo Dannlowski; Nils Opel; Lavinia A Steinmann; Katharina Dohm; Janik Goltermann; Maike Richter; Verena Enneking; Marcia Lippitz; Jonathan Repple; Marco Mauritz
Journal:  J Psychiatry Neurosci       Date:  2022-08-10       Impact factor: 5.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.